Sivaraman V, Yellon DM. Pharmacologic therapy that simulates conditioning for cardiac ischemic/reperfusion injury. J Cardiovasc Pharmacol Ther 2014; 19: 83-96.
Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003; 285: H579-88.
Kaljusto ML, Rutkovsky A, Stensløkken KO, Vaage J. Postconditioning in mouse hearts is inhibited by blocking the reverse mode of the sodium-calcium exchanger. Interact Cardiovasc Thorac Surg 2010; 10: 743-8.
Drenger B, Ostrovsky IA, Barak M, Nechemia-Arbely Y, Ziv E, Axelrod JH. Diabetes blockade of sevoflurane postconditioning is not restored by insulin in the rat heart: phosphorylated signal transducer and activator of transcription 3- and phosphatidylinositol 3-kinase-mediated inhibition. Anesthesiology 2011; 114: 1364-72.
Liu M, Zhou B, Xia ZY, Zhao B, Lei SQ, Yang QJ, et al. Hyperglycemia-induced inhibition of DJ-1 expression compromised the effectiveness of ischemic postconditioning cardioprotection in rats. Oxid Med Cell Longev 2013; 2013: 564902.
Badalzadeh R, Mohammadi M, Najafi M, Ahmadiasl N, Farajnia S, Ebrahimi H. The additive effects of ischemic postconditioning and cyclosporine-A on nitric oxide activity and functions of diabetic myocardium injured by ischemia/reperfusion. J Cardiovasc Pharmacol Ther 2012; 17: 181-9.
Li X, Zhao H, Wu Y, Zhang S, Zhao X, Zhang Y, et al. Up-regulation of hypoxia-inducible factor-1αenhanced the cardioprotective effects of ischemic postconditioning in hyperlipidemic rats. Acta Biochim Biophys Sin (Shanghai) 2014; 46: 112-8.
Xu Y, Ma LL, Zhou C, Zhang FJ, Kong FJ, Wang WN, et al. Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection. PLoS One 2013; 8: e76652.
Zhao HX, Wang YH, Wu Y, Li XY, Yang GZ, Ma XR, et al. Hyperlipidemia does not prevent the cardioprotection by postconditioning against myocardial ischemia/reperfusion injury and the involvement of hypoxia inducible factor-1α upregulation. Acta Biochim Biophys Sin 2009; 41: 745-53.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010; 8: 336-41.
Macleod MR, O'Collins T, Howells DW, Donnan GA. Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 2004; 35: 1203-8.
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomized trials. BMJ 2011; 343: d5928.
Moriguchi A, Otani H, Yoshioka K, Shimazu T, Fujita M, Okazaki T, et al. Inhibition of contractile activity during postconditioning enhances cardioprotection by restoring sarcolemmal dystrophin through phosphatidylinositol 3-kinase. Circ J 2010; 74: 2394-402.
Tsang A, Hausenloy DJ, Mocanu MM, Yellon DM. Postconditioning: a form of
Penna C, Perrelli MG, Tullio F, Angotti C, Camporeale A, Poli V, et al. Diazoxide postconditioning induces mitochondrial protein S-Nitrosylation and a redox-sensitive mitochondrial phosphorylation/translocation of RISK elements: no role for SAFE. Basic Res Cardiol 2013; 108: 371.
Wei C, Li H, Han L, Zhang L, Yang X. Activation of autophagy in ischemic postconditioning contributes to cardioprotective effects against ischemia/reperfusion injury in rat hearts. J Cardiovasc Pharmacol 2013; 61: 416-22.
De Paulis D, Chiari P, Teixeira G, Couture-Lepetit E, Abrial M, Argaud L, et al. Cyclosporine A at reperfusion fails to reduce infarct size in the in vivo rat heart. Basic Res Cardiol 2013; 108: 379.
Lee DS, Steinbaugh GE, Quarrie R, Yang F, Talukder MA, Zweier JL, et al. Ischemic postconditioning does not provide cardioprotection from long term ischemic injury in isolated male or female rat hearts. J Surg Res 2010; 164: 175-81.
Vessey DA, Kelley M, Li L, Huang Y. Sphingosine protects aging hearts from ischemia/reperfusion injury: Superiority to sphingosine 1-phosphate and ischemic pre- and post-conditioning. Oxid Med Cell Longev 2009; 2: 146-51.
Yu GG, Zeng XJ, Wang HX, Lu LQ, Zheng SP, Ma LQ, et al. Cytochrome P450 2J3⁄epoxyeicosatrienoic acids mediate the cardioprotection induced by ischaemic post-conditioning, but not preconditioning, in the rat. Clin Exp Pharmacol Physiol 2011; 38: 63-70.
Zhang G, Sun Y, Wang Y, Li X, Li T, Su S, et al. local administration of lactic acid and a low dose of the free radical scavenger, edaravone, alleviates myocardial reperfusion injury in rats. J Cardiovasc Pharmacol 2013; 62: 369-78.
Sachdeva J, Dai W, Gerczuk PZ, Kloner RA. Combined remote perconditioning and postconditioning failed to attenuate infarct size and contractile dysfunction in a rat model of coronary artery occlusion. J Cardiovasc Pharmacol Ther 2014; 19: 567-73.
Inserte J, Hernando V, Vilardosa Ú, Abad E, Poncelas-Nozal M, Garcia-Dorado D. Activation of cGMP/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling. J Am Heart Assoc 2012; 2: e005975.
Inserte J, Hernando V, Ruiz-Meana M, Poncelas-Nozal M, Fernández C, Agulló L, et al. Delayed phospholamban phosphorylation in post-conditioned heart favours Ca2+ normalization and contributes to protection. Cardiovasc Res 2014; 103: 542-53.
Li J, Loukili N, Rosenblatt-Velin N, Pacher P, Feihl F, Waeber B, et al. Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivo. PLoS One 2013; 8: e70331.
Ke JJ, Yu FX, Rao R, Wang YL. Adenosine postconditioning protects against myocardial ischemia-reperfusion injury though modulate production of TNF-α and prevents activation of transcription factor NF-kappaB. Mol Biol Rep 2011; 38: 531-8.
Xia JG, Xu FF, Qu Y, Song DG, Shen H, Liu XH. Atorvastatin post-conditioning attenuates myocardial ischemia reperfusion injury via inhibiting endoplasmic reticulum stressyrelated apoptosis. Shock 2014; 42: 365-71.
Fantinelli J, González Arbeláez LF, Mosca SM. Cardioprotective efficacy against reperfusion injury of EMD-87580: Comparison to ischemi cpostconditioning. Eur J Pharmacol 2014; 737: 125-32.
Gao J, Guo J, Li H, Bai S, Li H, Wu B, et al. Involvement of dopamine D2 receptors activation in ischemic post-conditioning-induced cardioprotection through promoting PKC-ε particulate translocation in isolated rat hearts. Mol Cell Biochem 2013; 379: 267-76.
Xiong J, Wang Q, Xue FS, Yuan YJ, Li S, Liu JH, et al. Comparison of cardioprotective and anti-inflammatory effects of ischemia pre- and postconditioning in rats with myocardial ischemia-reperfusion injury. Inflamm Res 2011; 60: 547-54.
Taki J, Higuchi T, Kawashima A, Fukuoka M, Kayano D, Tait JF, et al. Effect of postconditioning on myocardial 99mTc-annexin-V uptake: comparison with ischemic preconditioning and caspase inhibitor treatment. J Nucl Med 2007; 48: 1301-7.
Breivik L, Helgeland E, Aarnes EK, Mrdalj J, Jonassen AK. Remote postconditioning by humoral factors in effluent from ischemic preconditioned rat hearts is mediated via PI3K/Akt-dependent cell-survival signaling at reperfusion. Basic Res Cardiol 2011; 106: 135-45.
Zhang L, Ma J, Liu H. Protective effect of ischemic postconditioning against ischemia reperfusion-induced myocardium oxidative injury in IR rats. Molecules 2012; 17: 3805-17.
Wang NP, Pang XF, Zhang LH, Tootle S, Harmouche S, Zhao ZQ. Attenuation of inflammatory response and reduction in infarct size by postconditioning are associated with downregulation of early growth response 1 during reperfusion in rat heart. Shock 2014; 41: 346-54.
Tamareille S, Ghabour Na, Treguer F, Khachman D, Croué A, Henrion D, et al. Myocardial reperfusion injury management: erythropoietin compared with postconditioning. Am J Physiol Heart Circ Physiol 2009; 297: H2035-43.
Liu X, Jiang Y, Yu X, Fu W, Zhang H, Sui D. Ginsenoside-Rb3 protects the myocardium from ischemiareperfusion injury via the inhibition of apoptosis in rats. Exp Ther Med 2014; 8: 1751-6.
Hu X, Jiang H, Ma F, Xu C, Bo C, Wen H, et al. Similarities between ischemic preconditioning and postconditioning in myocardial ischemia/reperfusion injury. Int J Cardiol 2010; 144: 135-6.
Qiao X, Xu J, Yang QJ, Du Y, Lei S, Liu ZH, et al. Transient acidosis during early reperfusion attenuates myocardium ischemia reperfusion injury via PI3k-Akt-eNOS signaling pathway. Oxid Med Cell Longev 2013; 2013: 126083.
Zhou XL, Wa Ln, Xu QR, Zhao Y, Liu JC. Notch signaling activation contributes to cardioprotection provided by ischemic preconditioning and postconditioning. J Transl Med 2013; 11: 251.
Ren Y, Cai Y, Jia D. Comparative antiapoptotic effects of KB-R7943 and ischemic postconditioning during myocardial ischemia reperfusion. Cell Biochem Biophys 2013; 64: 137-45.
Wu Y, Gu EW, Zhu Y, Zhang L, Liu XQ, Fang WP. Sufentanil limits the myocardial infarct size by preservation of the phosphorylated connexin 43. Int Immunopharmacol 2012; 13: 341-6.
Varga ZV, Zvara A, Faragó N, Kocsis GF, Pipicz M, Gáspár R, et al. MicroRNAs associated with ischemia-reperfusion injury and cardioprotection by ischemic pre- and postconditioning: protectomiRs. Am J Physiol Heart Circ Physiol 2014; 307: H216-27.
Wu N, Zhang X, Jia P, Jia D. Hypercholesterolemia abrogates the protective effect of ischemic postconditioning by induction of apoptosis and impairment of activation of reperfusion injury salvage kinase pathway. Biochem Biophys Res Commun 2015; 458: 148-53.
Li B, Luo WJ, Chen R, Huang RM, Long L. The protective effect of ischemic postconditioning in correlation of tetralogy of fallot. Chin J Clin Thorac Cardiovasc Surg 2009; 16: 158-69.
Ji Q, Mei Y, Wang X, Feng J, Wusha D, Cai J, et al. Effect of ischemic postconditioning in correlation of tetralogy of fallot. Int Heart J 2011; 52: 312-7.
Durdu S, Sirlak M, Cetintas D, Inan MB, Eryılmaz S, Ozcinar E, et al. The efficacies of modified mechanical post conditioning on myocardial protection for patients undergoing coronary artery bypass grafting. J Cardiothorac Surg 2012; 7: 73.
Luo W, Li L, Chen R, Huang R, Lin G. Effect of ischemic postconditioning in adult valve replacement. Eur J Cardiothorac Surg 2008; 33: 203-8.
Luo W, Zhu Z, Huang R, Zhang Y. A comparison of cardiac post-conditioning and remote pre-conditioning in paediatric cardiac surgery. Cardiol Young 2011; 21: 266-70.
Luo W, Li B, Lin G, Chen R, Huang R. Does cardioplegia leave room for postconditioning in paediatric cardiac surgery? Cardiol Young 2008; 18: 282-7.
Luo W, Li B, Lin G, Huang R. Postconditioning in cardiac surgery for tetralogy of Fallot. J Thorac Cardiovasc Surg 2007; 133: 1373-4.
Laskey WK, Yoon S, Calzada N, Ricciardi MJ. Concordant improvements in coronary flow reserve and ST-segment resolution during percutaneous coronary intervention for acute myocardial infarction: a benefit of postconditioning. Catheter Cardiovasc Interv 2008; 72: 212-20.
Limalanathan S, Andersen GØ, Hoffmann P, Kløw NE, Abdelnoor M, Eritsland J. Rationale and design of the POSTEM (postconditioning in ST-elevation myocardial infarction) study. Cardiology 2010; 116: 103-9.
Hempel S, Miles J, Suttorp MJ, Wang Z, Johnsen B, Morton S, et al. Detection of associations between trial quality and effect sizes. Rockville (MD): Agency for Healthcare Research and Quality (US), 2012.
Freixa X, Bellera N, Ortiz-Pérez JT, Jiménez M, Paré C, Bosch X, et al. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. Eur Heart J 2012; 33: 103-12.
Dwyer NB, Mikami Y, Hilland D, Aljizeeri A, Friedrich MG, Traboulsi M, et al. No cardioprotective benefit of ischemic postconditioning in patients with ST-segment elevation myocardial infarction. J Interv Cardiol 2013; 26: 482-90.
Bousselmi R, Lebbi MA, Ferjani M. Myocardial ischemic conditioning: Physiological aspects and clinical applications in cardiac surgery. J Saudi Heart Assoc 2013; 26: 93-100.